Great analysis Respert! I have a question for you regarding the Pharmasett analogy - I think that their market cap might have been approx. 5 billion at the time of the offer from Gilead. Even though we all know that CYDY is ultimately worth way more than $11 billion, does the likelihood of a buyout offer of that magnitude become less likelihood at this time when our market cap is only $400 - 500 million?